Cart
sales@molnova.com
Atrial Natriuretic Peptide Substrate, [pS6] ANF 1-28
CAS No. ———
Atrial Natriuretic Peptide Substrate, [pS6] ANF 1-28( ——— )
Catalog No. M41422 CAS No. ———
Atrial Natriuretic Peptide Substrate, [pS6] ANF 1-28
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAtrial Natriuretic Peptide Substrate, [pS6] ANF 1-28
-
NoteResearch use only, not for human use.
-
Brief DescriptionAtrial Natriuretic Peptide Substrate, [pS6] ANF 1-28
-
DescriptionAtrial Natriuretic Peptide Substrate, [pS6] ANF 1-28
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight3143.5
-
Molecular FormulaC128H206N45PO42S2
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
6-Bromo-2-naphthol
6-Bromo-2-naphthol is?an electrophilic carbene intermediate.
-
(Ala11·22·28)-VIP (h...
(Ala11·22·28)-VIP (human, bovine, porcine, rat)
-
N-Benzylpalmitamide
N-benzylpalmitamide inhibits fatty acid amide hydrolase (FAAH) in a time-dependent manner and could potentially offer a good alternative for the treatment of pain, inflammation and CNS degenerative disorders.
